ARTICLE | Company News
Demegen, Pacgen deal
February 6, 2012 8:00 AM UTC
The companies added vaginal, dermatological and ophthalmic indications to a March 2005 deal granting Pacgen worldwide rights to Demegen's PAC-113 for oral candidiasis. PAC-113 is an oral mouth rinse ...